These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38095639)
21. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells. Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780 [TBL] [Abstract][Full Text] [Related]
22. XAF1 drives apoptotic switch of endoplasmic reticulum stress response through destabilization of GRP78 and CHIP. Lee KW; Hong HR; Lim JS; Ko KP; Lee MG; Chi SG Cell Death Dis; 2022 Jul; 13(7):655. PubMed ID: 35902580 [TBL] [Abstract][Full Text] [Related]
23. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Zhang TM; Liao L; Yang SY; Huang MY; Zhang YL; Deng L; Hu SY; Yang F; Zhang FL; Shao ZM; Li DQ Autophagy; 2023 Mar; 19(3):805-821. PubMed ID: 35920704 [TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Zhu LM; Shi DM; Dai Q; Cheng XJ; Yao WY; Sun PH; Ding Y; Qiao MM; Wu YL; Jiang SH; Tu SP Oncotarget; 2014 Jul; 5(14):5403-15. PubMed ID: 24980821 [TBL] [Abstract][Full Text] [Related]
25. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer. Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793 [TBL] [Abstract][Full Text] [Related]
26. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer. Wang Y; Liu P; Wang X; Mao H Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973 [TBL] [Abstract][Full Text] [Related]
27. Low expression of XIAP-associated factor 1 in human colorectal cancers. Ma TL; Ni PH; Zhong J; Tan JH; Qiao MM; Jiang SH Chin J Dig Dis; 2005; 6(1):10-4. PubMed ID: 15667552 [TBL] [Abstract][Full Text] [Related]
28. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification. Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. Kempkensteffen C; Fritzsche FR; Johannsen M; Weikert S; Hinz S; Dietel M; Riener MO; Moch H; Jung K; Krause H; Miller K; Kristiansen G BMC Cancer; 2009 Aug; 9():276. PubMed ID: 19664236 [TBL] [Abstract][Full Text] [Related]
30. Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114. Lin B; Ke Q; Li H; Pheifer NS; Velliquette DC; Leaman DW Cytokine; 2017 Nov; 99():186-193. PubMed ID: 28625874 [TBL] [Abstract][Full Text] [Related]
31. XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy. Pinho MB; Costas F; Sellos J; Dienstmann R; Andrade PB; Herchenhorn D; Peixoto FA; Santos VO; Small IA; Guimarães DP; Ferreira CG Urol Oncol; 2009; 27(4):382-90. PubMed ID: 18555708 [TBL] [Abstract][Full Text] [Related]
32. Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53. Steigerwald C; Rasenberger B; Christmann M; Tomicic MT Arch Toxicol; 2018 Aug; 92(8):2645-2648. PubMed ID: 29947891 [TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation. Bai Y; Ahmad U; Wang Y; Li JH; Choy JC; Kim RW; Kirkiles-Smith N; Maher SE; Karras JG; Bennett CF; Bothwell AL; Pober JS; Tellides G J Biol Chem; 2008 Mar; 283(11):6832-42. PubMed ID: 18192275 [TBL] [Abstract][Full Text] [Related]
34. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer. Chen YB; Shu J; Yang WT; Shi L; Guo XF; Wang FG; Qian YY Chin Med J (Engl); 2011 Oct; 124(20):3238-43. PubMed ID: 22088514 [TBL] [Abstract][Full Text] [Related]
35. A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells. Hatakeyama K; Yamakawa Y; Fukuda Y; Ohshima K; Wakabayashi-Nakao K; Sakura N; Tanizawa Y; Kinugasa Y; Yamaguchi K; Terashima M; Mochizuki T Gastric Cancer; 2015 Oct; 18(4):751-61. PubMed ID: 25216542 [TBL] [Abstract][Full Text] [Related]
36. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Huang Y; Wang F; Lin X; Li Q; Lu Y; Zhang J; Shen X; Tan J; Qin Z; Chen J; Chen X; Pan G; Wang X; Zeng Y; Yang S; Liu J; Xing F; Li K; Zhang H Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221653120. PubMed ID: 37788309 [TBL] [Abstract][Full Text] [Related]
37. Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor. Fang X; Liu Z; Fan Y; Zheng C; Nilson S; Egevad L; Ekman P; Xu D Int J Cancer; 2006 May; 118(10):2485-9. PubMed ID: 16353137 [TBL] [Abstract][Full Text] [Related]
38. USP7 and VCP Franz A; Valledor P; Ubieto-Capella P; Pilger D; Galarreta A; Lafarga V; Fernández-Llorente A; de la Vega-Barranco G; den Brave F; Hoppe T; Fernandez-Capetillo O; Lecona E Cell Rep; 2021 Oct; 37(2):109819. PubMed ID: 34644576 [TBL] [Abstract][Full Text] [Related]
39. X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin. Ju WC; Huang GB; Luo XY; Ren WH; Zheng DQ; Chen PJ; Lou YF; Li B Med Oncol; 2014 Dec; 31(12):273. PubMed ID: 25367849 [TBL] [Abstract][Full Text] [Related]
40. XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity. Han Y; Bai X; Liu S; Zhu J; Zhang F; Xie L; Liu G; Jiang X; Zhang M; Huang Y; Wang J; Li D; Zhang H; He Y; He S; Xia Y; Xu X; Xu F; Ma F J Virol; 2022 Sep; 96(17):e0077422. PubMed ID: 35972291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]